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Abstract 
Though viruses have generally been characterized by their pathogenic and more generally 
harmful effects, many examples of mutualistic viruses exist. Here I explain how the idea of 
mutualistic viruses has been defended in recent virology, and I explore four important 
conceptual and practical consequences of this idea. I ask to what extent this research modifies 
the way scientists might search for new viruses, our notion of how the host immune system 
interacts with microbes, the development of new therapeutic approaches, and, finally, the role 
played by the criterion of autonomy in our understanding of living things. Overall, I suggest 
that the recognition of mutualistic viruses plays a major role in a wider ongoing revision of 
our conception of viruses. 
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Highlights 
• Though viruses have generally been seen as harmful (e.g., pathogenic), many viruses 
are beneficial to their host. 
• Mutualistic viruses are found across species, including in Bacteria, Archaea, plants, 
insects, and mammals. 
• Beneficial viral effects on the host can be classified schematically into three 
categories: development, protection, or invasion capacities. 
• The recognition of mutualistic viruses can be seen as an important ingredient of a 
more general reconceptualization of viruses in current virology.  
• This recognition provides a useful bridge between medical and ecological-
evolutionary approaches in virology. 
 
 
1. Introduction 
Viruses have generally been characterized by their detrimental effects, particularly their 
pathogenic ones. Examples abound of human, animal, and plant viruses that reduce host 
fitness, and Section 2 below recalls that, given the number of past and present human deaths 
due to viruses, it is by no means surprising that viruses are generally perceived as harmful. 
In that context, the recent claim that many viruses can in fact be mutualistic, i.e., have 
beneficial effects on host fitness, was a bombshell to many (Ryan, 2009; Virgin, Wherry, & 
Ahmed, 2009; Roossinck, 2011). The aim of this paper is, via the analysis of several major 
examples of recently described mutualistic viruses, to assess the novelty of this claim as well 
as its conceptual and practical consequences. As explained below, the existence of mutualistic 
viruses has been known for some time, but the claim based on current data is different and 
much stronger that previous ones. Under its present form, the idea of mutualistic viruses 
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raises key questions about the way scientists might search for new viruses, microbe1-immune 
system interactions, the development of new therapeutic approaches, and, finally, the role the 
criterion of autonomy plays in our understanding of living things. I suggest that this idea can 
play an important role in a more general reconceptualization of viruses, at the interface 
between medical and ecological-evolutionary approaches.  
The structure of this paper is as follows. Section 2 explains why viruses have generally 
been conceived as harmful. Section 3 describes in detail several examples of mutualistic 
viruses. Section 4 draws four conceptual and practical consequences from the existence of 
mutualistic viruses. Section 5 concludes. 
 
2. Why viruses have generally been considered as harmful 
Viruses have been identified at the end of the 19th century as infectious agents found in a 
solution filtered thanks to a Chamberland-Pasteur filter (a filter that retains bacteria) (Lustig 
& Levine, 1992); (Bos, 1999); (Cann, 2012)). In the footsteps of Ivanovksi, Beijerinck 
identified the tobacco mosaic virus as an infectious agent (a “contagious living fluid”) 
exhibiting special features, in particular the capacity to pass through a filter that blocks 
bacterial agents ((van Helvoort, 1996); (Bos, 1999)). Similarly, it is the search for small-size 
infectious agents that led, in the first half of the 20th century, to the discovery of many viruses 
(including those of yellow fever, rabies, dengue fever, poliomyelitis, measles, rubella, etc.) 
(Hughes, 1977). Reflecting on these very important discoveries, Australian virologist and 
immunologist Frank Macfarlane Burnet (1899-1985) writes in his influential book Viruses 
and Man: “We can define a virus then as a microorganism responsible for disease which is 
capable of growth only within the living cells of a susceptible host – and which is normally 
considerably smaller than any bacterium.” (Burnet, 1955). Viewing viruses as pathogenic is 
                                                
1 Throughout this text, the notion of “microbe” includes all microscopic biological entities, including viruses, 
regardless of any decision about their living vs. non-living status.  
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consistent with the etymology of the word (from the Latin vira, “poison”), and with the basic 
assumption of the germ theory of disease (defended, in particular, by Koch and Pasteur), 
which asserts that diseases are due to germs (though there were tensions between the germ 
theory of disease and the first conceptualizations of viruses, because several scientists 
maintained that only bacteria could provoke diseases). 
The pathogenic view of viruses has been repeatedly expressed ever since, by both the 
lay public and many biologists. It is particularly true, of course, of medically oriented 
microbiologists, many of whom define viruses as “prototypic obligate intracellular 
pathogens” ((Nolan, Gaudieri, & Mallal, 2006); (Casadevall, 1998); (Kawamoto et al., 2003)). 
Significantly, similar definitions of viruses as pathogens are found in papers by molecular 
biologists (Anand, Schulte, Vogel-Bachmayr, Scheffzek, & Geyer, 2008), immunologists 
(Jirmo, Nagel, Bohnen, Sodeik, & Behrens, 2009), plant biologists (Wu, Lee, & Wang, 2011), 
and virologists (Cibulka, Fraiberk, & Forstova, 2012). Adding more weight to such 
definitions, a number of textbooks focus on viral pathogenesis (Nathanson, 2007), and Nobel 
Prizes awarded to the field of virology are often explicitly presented as rewarding the 
discovery of disease-causing viruses, such as HIV and human papilloma virus (which causes 
cervical cancer, and potentially other cancers as well) in 2008 (Weiss, 2008). Overall, as 
observed by William C. Summers, “The basic idea that viruses are the material basis for 
disease transmission has changed little in the past 150 years; what has changed is our 
understanding of the essential properties and biological capacities of viruses” (Summers, 
2014). 
Of course, pathogenicity (i.e., the capacity to cause disease) is not the only way 
viruses can be harmful. For example, some viruses reduce host fertility (Abbate, Kada, & 
Lion, 2015; Sait, Gage, & Cook, 1998), or manipulate host behavior (Hoover et al., 2011). It 
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seems more accurate, therefore, to say that viruses have generally been seen as fitness-
reducing entities, most of the time through their pathogenic effects. 
It is certainly not the aim of the present paper to deny that some viruses can cause 
significant harm. There have been dreadful viral infections in the past, including smallpox in 
18th century Europe (estimated to have killed 400,000 people each year) and, following the 
First World War, the pandemic of influenza virus that killed over 40 million people 
worldwide (Loo & Gale, 2007) – many more than the war itself. Today, there are still many 
harmful viral infections; for example, it is estimated that by 2015, the human 
immunodeficiency virus (HIV) had infected more than 30 million people, with 1.8 million 
new infections and 1.7 million deaths in 2013 alone (Murray et al., 2014). Furthermore, many 
of the health alerts in the world in the last two decades were related to novel emerging 
viruses, including Severe Acute Respiratory Syndrome (SARS) coronavirus, and the 2009 
pandemic influenza H1N1 (Chiu, 2013). 
 The immediate counterpart of the conception of viruses as infectious agents has been 
the exploration of how hosts are affected by those viruses, and the different antiviral defense 
mechanisms they can use. In particular, a key aspect of immunology has been devoted to 
understanding how hosts “fight” viruses. In textbook narratives about the historical sources of 
immunology, vaccination against different viral diseases is commonly the starting point (e.g., 
(Murphy, 2012)). This is related more generally to the interpretation of immune systems as 
defense systems, at war with pathogens, and especially viral pathogens ((Frank, 2002); (Clark, 
2008)). As the rest of this paper will show, however, it is inadequate to see viruses 
exclusively as harmful and, relatedly, to conceive of the immune system only as a defense 
system, selected for its capacity to eliminate microbes. 
 
3. Mutualistic Viruses 
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Though viruses have commonly been conceived as harmful, recent research has shown that 
many of them are neutral (not affecting host fitness) or even mutualistic (increasing host 
fitness) (Bao & Roossinck, 2013; Cadwell, 2015a, 2015b; Dennehy, 2014; Foxman & 
Iwasaki, 2011; MacDuff et al., 2015; Roossinck, 2008, 2011, 2015; Ryan, 2009; Shen, 2009; 
Stoltz & Whitfield, 2009; Virgin, 2014a). Here I focus on the case of mutualistic viruses. 
Mutualism is not a yes/no question, but rather a question of degree, and moreover it is often a 
contextual question (it depends on spatial and temporal conditions) (Méthot & Alizon, 2014; 
Van Baalen & Jansen, 2001). That said, the cases examined below are well-documented 
examples in which viruses clearly increase host fitness, or, in some cases, have even become 
indispensable to host development, survival, or reproduction. 
 In a mutualistic relation, the virus benefits most of the time from an appropriate niche, 
in which it can live and reproduce efficiently. The question is how the host can benefit. 
Viruses can increase host fitness in several ways. Three classes of positive effects on fitness 
can be schematically distinguished: they are development, protection, and invasion. Table 1 
offers an extensive list of mutualistic viruses, their hosts, and effects. In what follows I 
elaborate some particularly telling examples. 
 
3.1. Viruses can have a mutualistic effect on host development 
 First, a virus can have a beneficial effect on host development. A first illustration 
concerns cases in which the realization of the life cycle of an organism is dependent on the 
presence of a virus within the host. Mutualistic polydnaviruses of parasitoid wasps constitute 
a very important and widespread example of this phenomenon. Many wasps (Hymenoptera, 
Ichneumonoidea, Braconidae) paralyze their hosts (which are arthropods, principally of the 
order Lepidoptera, Coleoptera, Hymenoptera and Hemiptera), and lay their eggs inside them, 
where the wasp larvae then develop. (In koinobiont species, the wasp larvae grow within the 
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still living host, and ruthlessly feed on it.2) Normally, the host immune system would wall off 
the wasp eggs (through a phenomenon called “encapsulation”), and eliminate them. Yet 
particles of viral (polydnavirus) origin suppress this immune response. In other words, the 
wasp eggs can survive and develop only because a virus integrated into the wasp’s genome 
actively counters the immune defense of the host larva. Perhaps surprisingly, this 
phenomenon has been known for more than thirty years (Edson, Vinson, Stoltz, & Summers, 
1981), but it is only recently that it has been understood in detail ((Espagne et al., 2004); 
(Bézier et al., 2009); (Herniou et al., 2013); (Drezen, Chevignon, Louis, & Huguet, 2014)). 
It is also important to emphasize that the phenomenon described here is very frequent 
in nature. It is estimated that 30,000 species of endoparasitoid braconid and ichneumonid 
wasps have their own mutualistic viral species (Webb et al., 2006). The integration of 
polydnavirus into parasitoid wasps is also an evolutionarily ancient phenomenon, contrary to 
some other examples discussed below: it occurred several times, million years ago. In 
particular, polydnaviruses in the genus Bracovirus evolved approximately 100 million years 
ago from a nudivirus (Herniou et al., 2013).  
Though there is no doubt that the genetic sequences that suppress the host immune 
response and make possible the life cycle of the parasitoid wasps are of viral origins, one 
could consider that the virus has been so tightly integrated into the host genome that it is no 
longer possible to see the virus and the wasp as separate entities (Roossinck, 2015). However, 
one of the reasons why polydnaviruses are so fascinating is that, even though they have 
evolved into vertically transmitted agents, they continue to function in many respects like 
more traditional viruses ((Herniou et al., 2013); (Drezen et al., 2014); (Strand & Burke, 
2014); (Strand & Burke, 2015)). As noted by Herniou et al. (2013), bracoviruses in particular 
                                                
2 This phenomenon strongly impressed Darwin. It was a reason for him to doubt the existence of a potent and 
beneficent God: “I cannot persuade myself that a beneficent and omnipotent God would have designedly created 
the Ichneumonidae with the express intention of their feeding within the living bodies of caterpillars” (Letter to 
Gray, May 22, 1860). 
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are not fossil genomic remnants but active viruses, unlike most endogenous viral elements. 
Most classic viral functions have been conserved and bracoviruses undergo all the steps of a 
conventional virus cycle. Surprisingly, the main difference between polydnaviruses and 
classical viruses is the separation of the virus cycle between two cell types and hosts: the 
production of the infectious particles is done by calyx cells in the wasp ovaries, while the 
infection involves parasitized lepidopteran host cells. 
 A second example of a beneficial effect of a virus on host development concerns the 
role of endogenous retroviruses in the evolution of placenta in mammals. A retrovirus is an 
RNA virus that uses its own reverse transcriptase enzyme to produce DNA from its RNA 
genome, and then this DNA is integrated into the genome of the host cell. An endogenous 
retrovirus is a retrovirus that has been incorporated into the germline cells, and remains 
persistent in these cells. Recent research has shown that the evolution of placental mammals 
has been made possible thanks to an endogenous retrovirus. It was demonstrated first in sheep 
(Dunlap et al., 2006), and then in mice (Dupressoir et al., 2009), and it is certainly a 
phenomenon common to all mammals, including humans (Mallet et al., 2004). The fusion of 
cell membranes is required for the development of the placental syncytium, which is a major 
component of the immunological “barrier” of the fetus, and this syncytial fusion is possible 
only thanks to an endogenous retrovirus.  
So here again, the realization of an organism’s developmental cycle depends on the 
presence of an integrated virus. Interestingly, the event consisting in the incorporation of such 
a retrovirus occurred several times, independently, during mammalian evolution (Dupressoir 
et al., 2009). Thus placentation, a key event for all mammals including humans, has been 
made possible thanks to the incorporation of a virus into the mammal germline. This shows 
that mutualistic viruses can be involved in very significant evolutionary events. 
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 In other cases, the beneficial effect of a virus on host development is due not to an old 
evolutionary legacy but to the present integration of a virus into the host. A striking recent 
paper has shown that a mouse enteric virus, the murine norovirus (MNV), can play a key role 
in the development and physiology of the host (Kernbauer, Ding, & Cadwell, 2014). It is well 
known that germ-free mice exhibit aberrant intestinal morphology and deficiencies in their 
lymphocytic compartments, which has been taken as a demonstration that some commensal 
bacteria are indispensable for a normal development, in particular for the development of the 
gut immune system (Round & Mazmanian, 2009)3. Kernbauer and colleagues show that 
MNV infection of germ-free mice can restore intestinal morphology and mucosal immunity, 
without triggering strong inflammation and disease, which demonstrates that a virus can exert 
mutualistic effects, exactly as some gut bacteria do.  
An increasing number of biologists have started to study the “virobiota” (all the 
viruses that live in or on a host) and the “virome” (the set of all the genes of the virobiota), as 
a potentially crucial part of the “microbiota” and “microbiome”4, respectively ((Reyes et al., 
2010); (Moon & Stappenbeck, 2012); (Duerkop & Hooper, 2013); (Virgin, 2014b); (Cadwell, 
2015b)). The human virobiota is made of both bacteriophages (i.e., viruses of bacteria)5, and 
eukaryotic viruses (Virgin, 2014b). The study of the gut virobiota in health and disease seems 
to be particularly promising ((Reyes et al., 2010); (Reyes, Semenkovich, Whiteson, Rohwer, 
& Gordon, 2012); (Moon & Stappenbeck, 2012); (Norman et al., 2015); (Cadwell, 2015a)), 
and many authors are convinced that numerous mutualistic viruses will be discovered in the 
near future, in particular in humans and other mammals ((Lecuit & Eloit, 2013); (Kernbauer 
et al., 2014); (Cadwell, 2015b)). It is even possible that some beneficial effects on host 
                                                
3 For a philosophical analysis of symbiont-induced development, see (Pradeu, 2011, 2012) 
4 The “microbiota” refers to all the microbes that live in or on a host, and the “microbiome” to the set of all the 
genes of the microbiota. 
5 “Bacteriophages” or “phages” were discovered by Frederick Twort and Félix d’Hérelle in 1915-1917. They 
contributed significantly to the progress of molecular biology and bacterial genetics. On the many historical 
controversies around phages, see (van Helvoort, 1994). 
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development that have hitherto been attributed to mutualistic bacteria living in the host could 
in fact be due to mutualistic viruses.  Overall, viruses can play a pivotal role in one of the most 
fundamental biological processes – that is, the very construction of an organism through 
development. 
 
3.2. Viruses can have a mutualistic effect on host protection 
Second, a virus can have a beneficial effect on host protection, that is, on the capacity 
of the host to protect itself from pathogens or diseases. A well-documented example concerns 
the protective role of pararetroviruses in plants (Roossinck, 2005). Pararetroviruses play a 
decisive role in protecting the plant host (e.g., tomatoes) against other viruses, which for their 
part are pathogenic, by generating small interfering RNAs (siRNAs) against them (Staginnus 
et al., 2007). In other cases (e.g., petunias), pararetroviruses prevent the entry of pathogenic 
viruses into the meristem of the plant.  
 In mammals as well, some viruses protect the host against diseases. This protection 
can concern viral diseases or non-viral diseases. An example of protection against viral 
diseases is the demonstration that, in humans, AIDS progresses much more slowly in patients 
infected by flavivirus GB virus C (GBV-C, also designated “hepatitis G virus”, or HGV), 
which is a common, non-pathogenic, virus (Tillmann et al., 2001); (Bhattarai & Stapleton, 
2012). Examples of protection against non-viral diseases are the several forms of latent 
herpesvirus that protect against some bacterial infections (Listeria monocytogenes; Yersinia 
pestis) (Barton et al., 2007), and the lymphotrophic viruses that protect against type 1 diabetes 
(Oldstone, 1988). 
According to a recent study by Forest Rohwer’s group (Barr et al., 2013), 
bacteriophages adhering to the gut mucus layer provide their animal hosts with immunity 
against pathogenic bacteria (the bacteriophages induce a reduction of bacterial attachment to 
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the mucus, lyse incoming bacteria, and cause a significant diminution of epithelial cell death). 
Thus, these bacteriophages have a mutualistic relationship with their host, by conferring a 
previously unrecognized virus-based immunity. Host-microbial relationships in the gut are 
extremely rich and complex, in particular because different microbes can have antagonistic or 
stimulating effects one on the other. Much work remains to be done on the overall effects on 
the host of these intricate microbial interactions. 
 Some cases are even more fascinating and entangled. As we have seen, many 
parasitoid wasps realize their life cycle by laying their eggs in arthropod hosts. But some 
hosts have evolved ways to protect themselves against the parasitoid wasps and their 
polydnaviruses. For example, an aphid (Acyrthosiphon pisum) host can kill the developing 
wasp (Aphidius ervi) larvae, and it has long been known that this protection is mediated by a 
symbiotic bacterium, Hamiltonella defensa. In 2009, however, it was demonstrated that the 
protective effect of this symbiotic bacterium is in fact due to the presence of a symbiotic 
bacteriophage within the bacterium (Oliver, Degnan, Hunter, & Moran, 2009) (see also 
(Moran, Degnan, Santos, Dunbar, & Ochman, 2005)). In that case, it is the virus, located 
within a bacterium, that is responsible for the protective effect on the host. In the words of the 
authors, the evolutionary “interests” of the three partners are “aligned,” which means that by 
destroying the wasp larvae the bacteriophage increases not just its own fitness, but also the 
bacterium and the aphid fitness.  
Such “Russian dolls” of mutualistic entities are probably common in nature and 
constitute a powerful evolutionary and ecological force, though they can be difficult to study 
(Ferrari & Vavre, 2011). To put this simply, the interaction between the aphid Acyrthosiphon 
pisum and the parasitoid wasp Aphidius ervi could be described as ultimately an arms race 
between two viruses, with the bacteriophage on one side, and the polydnavirus on the other 
(more exactly, there is a fitness alignment between three actors on the one hand – the aphid, 
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the bacterium, and the bacteriophage – and between two actors on the other hand – the 
parasitoid wasp and the polydnavirus). The conclusion is that in many cases, viruses, though 
they are generally seen as paradigmatic pathogenic entities, can actually be pivotal for host 
protection. 
 
3.3. Viruses can have a mutualistic effect on host invasion capacity 
Third, a virus can have a beneficial effect on host invasion capacity, that is, its 
capacity to colonize new territories at the expense of conspecifics, or to invade its own host. 
Mutualistic viruses can particularly help their hosts colonize new territories. For example, 
some bacteria harboring lysogenic bacteriophages6 have an evolutionary advantage over 
bacteria that are not lysogenic for this bacteriophage, and this advantage can be important for 
both the invasion of new territories and the domination of a given territory (Bossi, Fuentes, 
Mora, & Figueroa-Bossi, 2003).  
Plants and animals also possess persistent viruses, with no acute phase, which can 
destroy other related populations of plants and animals. This phenomenon may have been an 
important driving force in human history too. It is estimated that, ten years after the European 
invasion, 90% of the native people in Americas were dead; it is likely that viruses (including 
the viruses of smallpox and influenza) played a significant role in the rapid elimination of 
entire populations (Bianchine & Russo, 1992).  
Another important example of a virus having a beneficial effect on the host’s invasion 
capacity concerns virulence factors in bacteria. Bacteria can better colonize their hosts thanks 
to some virulence factors (including toxins). It is now known that many of these virulence 
factors, including diphtheria toxin, Shiga toxins, and cholera toxin (Boyd & Brüssow, 2002) 
                                                
6 “Lysogeny” describes the condition of bacteriophages that have existed for many generations integrated into 
their bacterial host genomes. 
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are expressed by the genome of a bacteriophage and not by the genome of the bacterium 
itself. 
 Finally, mutualistic viruses can be at the center of much more complex ecological 
relationships. The panic grass, Dichanthelium lanuginosum, grows in soils that are extremely 
hot (>50°C). This thermal tolerance requires a mutualistic fungus, Curvularia protuberata. 
Yet, the thermal tolerance is in fact mediated by a symbiotic virus within the symbiotic 
fungus (Márquez, Redman, Rodriguez, & Roossinck, 2007).  
 
3.4. Conclusions about the different examples of mutualistic viruses presented in this 
section 
 Some important differences exist among the examples of mutualistic viruses examined 
in this section. For example, some viruses (e.g., wasp polydnaviruses and mammal 
retroviruses involved in placentation) are beneficial (and even indispensable) to the whole 
species (and, therefore, are evolutionarily ancient), while others (e.g., herpesviruses protecting 
the host against pathogens) are beneficial to the very organism that harbors them and, in some 
cases, are environmentally acquired at each generation. 
That said, we can conclude from all the examples examined here that it is no longer 
adequate to see viruses as generally harmful. Many viruses – found in bacteria, plants, and 
animals (including humans) – increase the fitness of their hosts, and in particular their 
capacities to develop, defend themselves, or compete with other organisms in the invasion of 
new niches (Table 1). 
What is the proportion of mutualistic viruses among all viruses? It is, unfortunately, 
impossible to answer this question. First, many viruses cannot be classified as entirely 
“mutualistic” or “pathogenic” since their interactions with the host can switch from one state 
to the other. Second, only a very limited number of viruses have been identified and studied 
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so far (Rohwer & Barott, 2013). Exploring viral biodiversity is one of the most exciting 
challenges of future biology, and this exploration in turn will shed light on the prevalence of 
mutualistic viruses. 
  
4. Conceptual and practical consequences of the existence of mutualistic viruses 
Why should biologists and philosophers or historians of biology should pay attention 
to the existence of mutualistic viruses? To what extent is it a novel and groundbreaking idea? 
Can it have an important impact on virology, from both a conceptual and practical point of 
view? In this section, I show that, even though the idea that viruses can be mutualistic is not 
entirely new, the data that support it are recent, and have made existing claims much more 
solid and exact. 
The idea that viruses can be mutualistic has already been expressed in the past. In 
particular, Edgar Altenburg (1888-1967) suggested that all organisms contained numerous 
“viroids,” that he saw as useful, or even indispensable to the host (Altenburg, 1946). For 
Altenburg, viroids could also give rise to pathogenic viruses, and to most cancers. Altenburg’s 
hypotheses, though highly speculative, were extremely stimulating, and they had an impact on 
biologists who tried, in the second half of the twentieth century, to emphasize the importance 
of symbioses in nature (e.g., (Margulis & Sagan, 2002); see also (Sapp, 1994)).  
Moreover, in many ecological and evolutionary approaches to viruses, the idea that 
viruses could enhance host fitness is well-accepted. As with any biological entity, a virus can 
be detrimental or beneficial to the fitness of another biological entity, depending on the 
circumstances (in particular, it can be beneficial at one period of time, and detrimental at 
another). For example, (Fellous & Salvaudon, 2009) analyze different cases of parasites being 
beneficial to the host in specific conditions, and they see viruses as one possible example of 
this (see also (Michalakis, Olivieri, Renaud, & Raymond, 1992)).  
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It would, therefore, be misleading to claim that the idea that viruses can be mutualistic 
is entirely new. And yet the present claim is clearly different from older ones. While the idea 
of mutualistic viruses in the past was highly speculative and based on a very limited number 
of examples, current research offers copious data about a wide diversity of examples across 
many species, as well as key molecular details about how the virus and host interact (Virgin et 
al., 2009; Roossinck, 2011, 2015; Cadwell, 2015b). For most scientists, there is a significant 
difference between a speculative idea and its empirical demonstration, and it is precisely this 
gap that recent data have filled in. Indeed, the current claim that viruses can be mutualistic 
may be seen as an important contribution to a more general revision of our conception of 
viruses. What is particularly significant is that the notion of mutualistic viruses, by 
undermining the still dominant view that viruses are generally harmful, can have key practical 
consequences on research in virology. Four of these conceptual and practical impacts can be 
explored here: the impact on how scientists search for new viruses, on the conception of how 
the host immune system interacts with microbes, on the potential use of viruses as therapeutic 
agents, and on the criterion of autonomy in the definition of living things. 
 
4.1. A change in the way scientists might search for new viruses 
One of the main reasons why mutualistic viruses have long been overlooked is simply that 
people did not think that viruses could be beneficial to their hosts, and therefore did not 
search for them (Virgin et al., 2009). Switching from the classic view to a conception 
according to which viruses can have all sorts of ecological interactions with other microbes 
and with their hosts opens up a whole new world for virus research.  
This is in particular what has strikingly happened in recent marine virology, where, 
with the help of new technological advances including viral metagenomics, viruses have been 
proved to be much more diverse than expected (more than 5,000 viral genotypes or species in 
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100 liters of sea water, and up to 1 million species in 1 kg of marine sediment), and they are 
able to “manipulate” their environments (including their virus, protist, and metazoan 
environments) in many different ways (Rohwer & Thurber, 2009). As Rohwer and Thurber 
say, “So far, the study of marine viruses has been dominated by the search for pathogens, but 
this will need to change if we are to appreciate the diverse ways that viruses affect life on 
Earth.” (On virus ecology, see O’Malley, this special issue). 
The view that viruses can be mutualistic also has major potential consequences on 
medicine: until recently, looking for a virus meant in most cases looking for a virus associated 
with a specific pathogenic state, whereas now doctors and medically-oriented microbiologists 
may expect to find viruses associated with all sorts of neutral or fitness-enhancing effects (for 
more on the medical consequences of mutualistic viruses, see 4.3). 
 
4.2. A modification of our conception of how the host immune system interacts with 
microbes 
A crucial consequence of what has been said above about resident and mutualistic viruses is 
that one should reject the dominant view according to which the normal healthy situation for a 
given organism, and in particular for a human being, would be the absence of infection. All 
living things harbor numerous viruses as part of their normal constitution and functioning. A 
healthy human is infected by more than ten permanent chronic systemic viruses (including 
herpesviruses, polyomaviruses, anelloviruses, adenoviruses, papillomaviruses), and this 
number may in fact be far higher (Virgin, 2014b). The immune system cannot be defined 
anymore as a self-nonself discrimination system, given the huge number of commensal 
bacteria and viruses that live in a human being (Mokili, Rohwer, & Dutilh, 2012), and the fact 
that these genetically foreign components are not rejected, but rather immunologically 
regulated (Pradeu, 2012). 
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Most resident viruses do not cause harm to the host, and, as we saw, some of them are 
even useful, while others seem to do very little damage. The fact that a standard human being 
is infected by many viruses is largely underestimated in the use of control individuals in 
experimental settings and in the study of medical cohorts (Virgin et al., 2009). Moreover, lab 
organisms that are considered as identical simply because they possess the same genome are 
in fact, in most cases, not identical from the point of view of their virome, and this mere fact 
could potentially undermine (or at least alter) many experimental results.  
 Relatedly, in everyday life, a healthy immune system, far from being turned off, is 
actually in a constant state of basal activation, in particular through continuous stimulations 
by resident viruses. This “immunological imprint” (Virgin et al., 2009) is central to 
understanding both the normal functioning of the immune system and the way it will respond 
to novel encounters with other microbes. When it is infected by chronic viruses (or other 
chronic microbes), the immune system reaches a new equilibrium. These continuously 
exposed viral antigens subsequently constitute the new normal situation for the immune 
system. In other words, they form the new reference point with regard to which the immune 
system will detect discontinuities (Pradeu, Jaeger, & Vivier, 2013).  
 Because all animals and plants harbor many viruses, immunologists and 
microbiologists are increasingly taking stock of the complexity of host-microbe interactions, 
or rather host-microbe-microbe interactions. Indeed, when a host is infected by a microbe, it 
is crucial to understanding not only how the host will react, but also how other (resident and 
external) microbes will react. The field of co-infection7 studies (e.g., (Virgin, 2007); (Lijek & 
Weiser, 2012); (Alizon, de Roode, & Michalakis, 2013); (Osborne et al., 2014); (Reese et al., 
2014)) focuses on that question. When a host is immunocompromised after being infected by 
a microbe, other microbes (opportunistic ones) might invade it (as happens with HIV, for 
                                                
7 In that context, what “infects” the host is not necessarily harmful; it can be dangerous, benign, or mutualistic. 
 18 
instance). Sometimes, two pathogens are much more dangerous if they attack their host 
together, leading to a combined assault (Jamieson et al., 2013). In many other cases, resident 
viruses protect the host against pathogenic microbes, as happens with latent herpesviruses that 
protect the host against Listeria monocytogenes and Yersinia pestis bacteria (Barton et al., 
2007), as explained above. Overall, strong evidence supports the view that infection by 
chronic viruses constantly stimulates the immune system, making it able to respond better to 
different pathogens (Virgin, Wherry and Ahmed 2009). Although our understanding of viral 
infections and immune responses comes primarily from the study of acute infections, it seems 
crucial, given the ubiquity of chronic viruses, including many mutualistic viruses, to re-think 
radically host-virus interactions (Virgin et al., 2009). 
 Taking into account mutualistic viruses leads to a new, much more “ecological” view 
of the immune system and its interactions with microbes. According to the microbes it meets 
and the microbes it harbors (among which viruses seem to play a decisive role), each living 
thing reaches a complex ecological equilibrium, which can be relatively stable but can also be 
modified in some circumstances. 
 
4.3. Virotherapy: The development of new therapeutic approaches 
 Attenuated or inactivated viruses have long been used for vaccination. But the 
existence of mutualistic viruses opens up new therapeutic avenues, particularly the use of 
bacteriophages to fight pathogens, the possibility of manipulating partners in co-infections, 
and the use of viruses to eliminate tumors.  
First, it is in principle possible to eliminate or control pathogenic bacteria in a host 
through the use of bacteriophages (viruses of bacteria) that can kill those bacteria (thus 
creating an “alignment of fitness” of the host and the bacteriophage against the bacteria). 
“Phage therapy” was popular in several countries of the Soviet Union, especially Poland and 
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Georgia, but it was often neglected or considered too dangerous in Western countries ((Stone, 
2002); (Chanishvili, 2012)). Yet recent years have witnessed a striking resurgence of interest 
in phage therapy, not least because of a growing concern about resistance to antibiotics 
among many bacteria ((Reardon, 2014); (Blaser, 2014); (Matsuzaki, Uchiyama, Takemura-
Uchiyama, & Daibata, 2014); (Kingwell, 2015)). The aim is not to replace antibiotics, but to 
complement them, in particular for targets resistant to particular antibiotics. Phage therapies 
can be effective against multidrug resistant bacteria, and, because of the high specificity of 
phages for given bacterial strains, they are unlikely to modify the host normal flora 
(Matsuzaki et al., 2014). Different strategies can be used in phage therapy (Viertel, Ritter, & 
Horz, 2014), including direct use of bacteriophages to target bacteria, engineered phages 
((Nobrega, Costa, Kluskens, & Azeredo, 2015); on the use of “phage cocktails”, see (Chan, 
Abedon, & Loc-Carrillo, 2013)), combinations of phages with antimicrobial substances, the 
use of lytic enzymes (in particular endolysin, e.g., (Gupta & Prasad, 2011)), and the phage-
mediated prevention of antibiotic resistance. Interesting recent results in phage therapy have 
been found for several bacterial infections, including infections of the urinary/genital tract 
(Międzybrodzki et al., 2012) and pulmonary infections (Abedon, 2015); they could also play 
an important role in the gut to improve gut disorders (Dalmasso, Hill, & Ross, 2014).  
Importantly, there are currently no phage applications for humans that have either 
been approved or are in Phase III clinical trials in the European Union or the USA (Viertel et 
al., 2014). Nonetheless, things could change rapidly. Following the decision of the European 
Union in 2014 to prioritize the development of phage therapy8, several research groups have 
accelerated their involvement in that domain, and two important phase II clinical trials have 
started in 2015 (Kingwell, 2015).  
                                                
8 In particular, the EU contributed €3.8 million to the “Phagoburn” project, which aims at exploring the use of 
phage therapy to treat burn wounds infected with bacteria (Reardon, 2014). 
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 Some people might reject the idea that viruses that kill pathogens should be considered 
“mutualistic,” but what is considered crucial here is the alignment of fitness between a host 
and a virus, whether that virus naturally possesses the capacity to eliminate the pathogen or 
has been engineered to do so. In addition, it seems likely that the recent resurgence of 
virotherapy research has been in part made possible by the growing recognition that viruses 
are not necessarily harmful to the host. 
Second, as our knowledge of the ecological interactions occurring within a given host 
progresses, we can imagine being able to manipulate co-infections. For example, it seems 
possible to stimulate (or maintain) a given virus to fight or control a pathogen (a bacterium, 
fungus, helminth, or virus). 
Finally, an extremely stimulating avenue consists in the use of viruses that can kill 
tumor cells, called “oncolytic viruses” ((Russell, Peng, & Bell, 2012); (Burke, Nieva, Borad, 
& Breitbach, 2015)), whether naturally (Roberts, Lorence, Groene, & Bamat, 2006) or 
because they have been engineered. The field already has a rich history (Kelly & Russell, 
2007), but very promising results have been obtained recently, with no less than nine different 
virus families current being tested, including some in phase III clinical trials (Miest & 
Cattaneo, 2014). Because oncolytic vaccines can be engineered to kill tumor cells directly, 
modulate the kinetics of the antitumor immune response and reverse the immunosuppressive 
actions of the tumor, many specialists predict that they will play a decisive role in future 
anticancer therapies (Elsedawy & Russell, 2013), most likely in synergy with other 
components of immunotherapies (that is, the stimulation of the immune system through 
different ways, so that it eliminates tumors) ((Coffin, 2015); (Snyder, Zamarin, & Wolchok, 
2015)).  
 
4.4. A re-evaluation of the criterion of autonomy in our understanding of living things 
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Viruses are generally considered as dependent on a host to complete their life cycle, that is, as 
heteronomous (as opposed to autonomous) entities. This has served as one of the main 
arguments to exclude viruses from the category of living things (e.g., Moreira & López-
García, 2009).  
Yet what has been shown above, namely that viruses can be mutualistic, converges 
with arguments that the criterion of autonomy to define living beings seems very fragile (see 
(Dupré & O’Malley, 2009), and Dupré and Guttinger, this special issue). First, some viruses 
can realize host-independent morphogenetic processes (e.g., growing long filamentous tails) 
outside a host (Häring et al., 2005). Second, recent research on symbiosis and mutualism has 
shown that virtually every living thing is dependent on other living things, often of a 
microscopic nature, for its survival and its reproduction. Organisms as diverse as plants, 
marine animals, insects or mammals harbor huge quantities of microbes that play an 
indispensable role in their physiological activities, digestion, immune defense, development, 
etc. ((M. J. McFall-Ngai, 2002); (Pradeu & Carosella, 2006); (Pradeu, 2012); (M. McFall-
Ngai et al., 2013); (Gilbert & Epel, 2015)). Each human, for example, hosts trillions of 
symbiotic bacteria, which are acquired from the environment, and are indispensable for 
digestion, normal development, and normal functioning of the immune system ((Bäckhed, 
Ley, Sonnenburg, Peterson, & Gordon, 2005); (Round & Mazmanian, 2009)).  
Obligate mutualisms are widespread in nature. These obligate mutualisms can 
associate a host with bacteria, archaea, fungi or, as shown here, viruses. But if obligate 
mutualisms are so common, why should we consider viruses apart from the rest of the 
biological world under the pretext that they are “dependent” on a host? For instance, many 
bacteria cannot be cultured outside their host (this includes Chlamydia trachomatis (Byrne, 
2003), but also, for instance, many members of the human gut microbiota ((Goodman et al., 
2011); (Stewart, 2012)). Moreover, even if one focuses on parasitic interactions, there exist 
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many obligate intracellular parasitic bacteria (e.g., Carsonella ruddii) with less than 150 
genes. Overall, “heteronomy” (that is, the fact for a biological entity to be dependent on other, 
persistent biological entities) (Pradeu, 2012) is ubiquitous in the biological world, so one of 
the main arguments to separate viruses from the rest of the biological world breaks down. 
So could viruses be considered as “organisms”? (See also Forterre, this special issue). 
In previous work, I have suggested that any entity that engages in physiological interactions 
controlled by an immune system should be considered as an organism ((Pradeu, 2010); 
(Pradeu, 2012)). That view promotes the role of the immune system in the definition of 
organismality because the immune system constitutes a principle of inclusion and exclusion, 
in the sense that it determines what is part of a common entity, and what is excluded from it. 
Importantly, this criterion of inclusion-exclusion is not based on the origin of the entities 
under consideration (that is, on the opposition between the endogenous “self” and the 
exogenous “nonself”): resident bacteria and viruses in an animal, for example, are part of that 
animal (Pradeu, 2010).  
Traditionally, viruses are not considered as organisms because they are said to lack 
metabolism (though this traditional view is questioned by some virologists, such as Claverie 
and Abergel, this special issue). But would viruses count as organisms with the 
“immunological view” presented here? For the moment, the answer is negative, because no 
formal immune system has been identified in viruses, contrary to the situation found in 
Bacteria and Archaea following the groundbreaking discovery of the CRISPR-Cas system 
(Barrangou et al., 2007). Nonetheless, future studies might well unravel an immune system of 
some kind in viruses, as some giant viruses can apparently be infected by virophages (viruses 
of viruses) ((La Scola et al., 2008); (Pearson, 2008); (Fischer & Suttle, 2011); (Yau et al., 
2011)). It therefore seems extremely likely that they have evolved defense strategies against 
these potential invaders. From an immunological point of view, therefore, viruses could be 
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considered as “organisms”, if future research confirms that they possess immune-like 
mechanisms. 
Be that as it may, it would still be very difficult to maintain that viruses are different 
from the rest of the biological world simply on the basis of the “lack of autonomy” argument. 
Autonomy clearly comes in degrees, and dependency of a biological entity on one or several 
other biological entities seems to be one of the most common features on Earth. 
 
5. Conclusion 
Viruses, which may well constitute the most abundant biological entities on Earth, remain 
largely unknown. In particular, mutualistic viruses, that is, viruses that increase host fitness, 
have accompanied us for a long time, but have remained largely “invisible”, and almost 
entirely neglected. 
 Two scientific and philosophical conclusions emerge from my discussion. The first 
concerns reconceptualizing biological individuality, autonomy, and competition. Viruses are 
everywhere in, on, and around living things, from prokaryotes to plants, fungi, and animals; 
they are sometimes detrimental, and at other times useful or even indispensable. By their 
ubiquity and diverse functional roles in every possible host, viruses extend the view that 
biological individuals are not autonomous but, on the contrary, heterogeneous (i.e., made of 
entities of different origins, often belonging to different kingdoms) and heteronomous (i.e., 
dependent, to some degree, on other biological entities to complete their life cycle). 
Moreover, ecological and evolutionary competition needs to be re-conceptualized, both 
spatially and temporally. Competition occurs not between selfish, autonomous, and 
homogeneous entities, but between temporarily constituted associations or aggregates (some 
of them long-lasting, others transient). In a given context, the three actors of the hierarchy 
made by a virus in a fungus in a plant (Márquez et al., 2007) help each other and constitute a 
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collaborative unit, in competition with other composite biological entities; however, in 
another context, this fitness alignment can break down. The study of biological competition 
and cooperation thus requires the careful investigation of how ecological interactions between 
and within hosts are established and broken down. Admittedly, many studies in ecology and 
evolution already pay attention to this highly dynamic nature of competitive/cooperative 
interactions, but my suggestion is that seeing the biological world through a viral lens 
strengthens this approach, and even makes it inevitable. 
The second consequence of including viruses is more sociological in nature, but may 
also have more extended conceptual implications. It has often been observed that medically-
oriented microbiology on the one hand, and evolutionarily and ecologically-oriented 
microbiology on the other, rarely interact either in research or in teaching (Smith, Rubinstein, 
Park, Kelly, & Klepac-Ceraj, 2015). Findings of mutualistic viruses now bring together these 
two branches of microbiology. Viruses are central to both human health and disease. They 
interact with us and regulate our relations with other resident entities, including bacteria, 
helminthes, and fungi. It is increasingly recognized that being infected by viruses is the norm 
rather than a deviation and resident viruses are a fundamental component of our basal 
immunity (Virgin, 2014a). They are, therefore, likely to play a key role in how we respond to 
any potentially pathological threat. These rich and reciprocal interactions call for the adoption 
by medical doctors of a “multiple infection” perspective, which draws on ecological and 
evolutionary concepts and models (Cadwell, 2015b; Choffnes, Olsen, & Mack, 2014). In turn 
ecologists and evolutionary biologists could avail themselves of the extensive molecular data 
accumulated by the medical sciences, especially about resident viruses (Woolhouse, Webster, 
Domingo, Charlesworth, & Levin, 2002). If this combination of medical and evolutionary-
ecological approaches in microbiology is realized in teaching practice, we can expect from the 
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new generation of microbiologists an enriched vision of microbes and our interactions with 
them. 
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Type of 
mutualism 
Virus Host Effect References 
Development 
Polydnavirus Parasitoid wasps 
Indispensable for the development 
of the wasp eggs in the host 
; (Espagne et al., 
2004); (Bézier et al., 
2009);  
(Herniou et al., 2013) 
Endogenous 
retroviruses Mammals 
Made placentation possible (Dunlap et al., 2006); 
(Dupressoir et al., 
2009) 
Murine norovirus Mice 
Can replace the beneficial effect of 
commensal bacteria on intestinal  
development and homeostasis 
(Kernbauer et al., 
2014) 
Protection 
against a 
pathogen or 
disease 
Pararetroviruses Plants 
Protection against pathogenic 
viruses 
(Roossinck, 2005); 
(Roossinck, 2008);  
(Roossinck, 2015) 
Flaviviridae viruses Humans Decrease in HIV infection (Tillmann et al., 2001) 
Herpesviruses Mice Protection against bacterial infections 
(Barton et al., 2007) 
Lymphotrophic 
viruses Mice 
Protection against diabetes (Oldstone, 1988) 
Oncolytic viruses Mice, humans 
Elimination of tumors (Parato, Senger, 
Forsyth, & Bell, 
2005); (Miest & 
Cattaneo, 2014) 
Retrovirus, with 
ongoing 
endogenization 
Koalas 
(Probably) Immune protection (Ryan, 2009);  
(Tarlinton, Meers, & 
Young, 2006) 
 
Bacteriophages 
Hamiltonella 
defensa within 
aphid host 
Elimination of parasitoid wasp (Oliver et al., 2009) 
Bacteriophage 
within different 
animal hosts (e.g., 
Cnidarians, fish, 
humans) 
Protection against pathogenic 
bacteria 
(Barr et al., 2013) 
Invasion of 
new hosts or 
Lysogenic 
bacteriophages Bacteria 
Elimination of bacterial competitors (Bossi et al., 2003) 
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niches Bacteriophages Bacteria Invasion of host (Boyd & Brüssow, 2002) 
Fungal virus Fungus within a plant 
Thermal tolerance (Márquez et al., 2007) 
Table 1. Examples of mutualistic viruses (based in particular on (Roossinck, 2011, 
2015)). 
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